On the other hand, ATM-deficient cancer cells are strongly nononcogene addicted to DNA-PKcs for survival after DNA damage, to such an extent that DNA-PKcs inhibition sensitizes ATM-deficient tumors to genotoxic chemotherapy. This evidence concerns the gene PRKDC and cancer.